Investcorp Growth Opportunity Fund files SEBI Takeover Disclosure under Regulation 31(4) for Nephrocare

M&A / JV 18 Jun 2026 · Announced· ✓ Verified

Investcorp Growth Opportunity Fund has submitted a disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, to NSE. This disclosure is required when an investor acquires or proposes to acquire shares resulting in substantial shareholding or change of control. The filing indicates either a completed or announced acquisition event in Nephrocare Health Services Limited, a healthcare services provider operating dialysis and nephrology clinics under the Nephroplus brand.

Why it mattersThe Regulation 31(4) disclosure triggers mandatory open offer and regulatory scrutiny under SEBI Takeover Regulations; exact shareholding threshold and consideration structure will be clarified in the formal disclosure document and subsequent announcements.
Counsel—
SectorPharma & Healthcare
[object Object][object Object][object Object][object Object][object Object][object Object][object Object][object Object]

Sources

Open in the live tracker →

Related deals